PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Sep-2024 Vapourtec invests in future with Bristol CDT partnership Vapourtec
12-Sep-2024 QL Biopharm Presented Results from Phase 1c Clinical Study on its Novel Once-Monthly GLP-1RA ZT002 at EASD 2024 Beijing QL Biopharmaceutical Co., Ltd
12-Sep-2024 Moderna R&D Day Highlights Progress and Strategic Priorities AccessWire
12-Sep-2024 Birmingham Health Partners Centre for Regulatory Science and Innovation director appointed University of Birmingham
12-Sep-2024 PharmaSGP continues dynamic growth path in the first half of 2024 PharmaSGP Holding SE
12-Sep-2024 PharmaSGP Holding SE resolves on public share repurchase offer to buy back own shares for up to 594,405 shares PharmaSGP Holding SE
12-Sep-2024 T-Cell Therapy Market to Exhibit a Remarkable 23.8% CAGR: Industry Share, Size, Demand, Trends, Business Growth Acumen Research and Consulting
12-Sep-2024 Choosing the Right Clinical Research Institute: A Step-by-Step Guide with Fusion Technology Solutions Fusion technology solutions
11-Sep-2024 Dr. Amir Bajoghli and Skin & Laser Dermatology Center Offer Advanced Vitiligo Treatment Options AccessWire
11-Sep-2024 Grey Wolf Animal Health to Present at the 2024 Planet MicroCap Showcase in Vancouver AccessWire
11-Sep-2024 Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million AccessWire
11-Sep-2024 Candid Health Announces $29 Million Series B Led by 8VC to Transform Revenue Cycle Automation AccessWire
11-Sep-2024 Curtiss Dentistry Introduces Planmeca Same-Day Dentistry in Maryville, TN AccessWire
11-Sep-2024 SMC accepts bispecific antibody TECVAYLI®▼ (teclistamab) for eligible patients with relapsed and refractory multiple myeloma Johnson & Johnson
11-Sep-2024 Best of Denton County 2024: Botox Bar Argyle Takes Home Best Cosmetic Injector Award AccessWire
11-Sep-2024 San Diego-Based Shoreline Recovery Center Works With Clients on Pursuing Aftercare for One of the World’s Public Health Crises AccessWire
11-Sep-2024 PRODUCTLIFE GROUP ACQUIRES OUTCOMES’10, EXPANDING EUROPEAN MARKET ACCESS CAPABILITIES PRODUCTLIFE GROUP
11-Sep-2024 Willbe. brings groundbreaking approach to perimenopause and longevity to the PAUSE Live Event Willbe.
11-Sep-2024 MHRA authorization of Dupixent (dupilumab) marks a significant step forward as the UK moves closer to the first ever targeted biologic for the treatment of uncontrolled COPD Sanofi
11-Sep-2024 Nxera Pharma’s Partner Centessa Announces Positive Interim Phase 1 Clinical Data with its Novel Orexin Receptor 2 (OX2R) Agonist, ORX750, in Acutely Sleep-Deprived Healthy Volunteers Nxera Pharma